Episode Details
Back to EpisodesBenzinga Interviews with MariMed, AYR Wellness, and InMed Pharmaceuticals
Description
Jesse Redmond, Head of Cannabis at Water Tower Research, reports live from the Benzinga Cannabis Capital Conference in Chicago. Jon Levine, CEO of MariMed, joined us to discuss the steps the firm has taken to make 2023 such a successful year. He shares his thoughts on the recent political progress and gives us a preview of the firm’s 2024 game plan. David Goubert, CEO of AYR Wellness, shares how his background in luxury retail has helped improve AYR’s operations. We also touch on the major markets that may flip adult-use in 2024 and he shares his priorities as we enter the new year. Finally, Shane Johnson, Senior Vice President of InMed Pharmaceuticals, discusses its rare cannabinoid business. InMed acquired BayMedica and he explains how the businesses are complementary and what has been driving the firm’s strong top-line growth. We also touch on its most popular products and how the firm is positioning for success in 2024.